Chinese electric vehicle manufacturers have introduced advanced headlight technology capable of projecting full-color films onto walls, surpassing current US adaptive lighting systems and signaling a significant leap in automotive multifunctionality and safety integration.
China’s pharmaceutical sector is transitioning from a low-cost domestic producer to a significant global innovator, driven by extensive investments and a large domestic market. While regulatory and geopolitical hurdles remain, the industry is poised to accelerate its international influence and reshape global pharmaceutical competition.
China’s revised Anti-Unfair Competition Law, effective October 15, 2025, significantly broadens regulatory oversight with extraterritorial implications, intensifies digital market controls, and introduces personal liability for executives, compelling multinational companies to reassess compliance and strategic engagement with the Chinese market.
